Popular contraceptives containing DROSPIRENONE (DRSP) are often referred to as “YAZ” or “YASMIN“. The hormonal contraceptives are birth control pills intended to prevent pregnancy when used as directed. DROSPIRENONE (DRSP) is the progestin that combines with an estrogen to prevent an egg from meeting sperm and potentially causing a pregnancy. At this time, all DROSPIRENONE (DRSP) containing birth control pills have 3 mg of DROSPIRENONE (DRSP). Today, in 2012, popular pills containingDROSPIRENONE (DRSP) include the trademarked YASMIN, YAZ, BEYAZ & SAFYRAL
The pills are manufactured by BAYER HEALTHCARE PHARMACEUTICALS and have become the subject of widespread litigation in the United States.
This litigation is often referred to as a Mass Tort because it involves thousands of claimants. While they were approved for use in by the U.S. Food & Drug Administration (“FDA“), this does not mean they are as safe as claimed. In fact, the pills have become the subject of over 13,000 lawsuits by girls and women claiming personal injuries. Sadly, some cases involve YAZ Wrongful Death Claims where a family member has passed and the pills are alleged to have contributed to, or caused, the death. Other cases involve YAZ side effects that were allegedly not adequately warned about, in the form of blood clot injuries and complications. While blood clots are a known risk of all forms of hormonal contraceptives, DROSPIRENONE (DRSP) was a new progestin that scientific studies have proven was riskier and more likely to cause or contribute to causing a blood clot than other older birth control pills.
Our office is actively investigating cases, and representing girls and women that have suffered injuries from use of a DROSPIRENONE (DRSP) containing birth control pill. This includes girls and women that have suffered blood clot injuries from use of pills containing DROSPIRENONE (DRSP) include the trademarked YASMIN, YAZ, BEYAZ &SAFYRAL or their generic equivalents. Blood clots can manifest themselves in the lungs as Pulmonary Emboli or in the legs as a Deep Vein Thrombosis. In summary, we are actively investigating cases involving DROSPIRENONE (DRSP) containing birth control pills and the following:
The history of DROSPIRENONE (DRSP) containing birth control has been marked by $20 Million Dollars in fines requiring corrective advertising because the company promoted the pills in violation of a prior settlement agreement and overstated the benefits of the pills without adequately emphasizing their risks. Multiple scientific studies since 2009 have found the pills increase the risk of blood clots, in comparison to other older types of pills available to users, thus calling into question why any 1st time user of a birth control pill would choose a DROSPIRENONE (DRSP) containing pill. In October 2012, a study was released again calling into question the safety profile of these pills and finding that the initiation of new use of DRSP containing pills was associated with a 77% increase in the risk of hospitalization for a blood clot and that such pills “should be used cautiously.
On October 30, 2012, BAYER released information in their “Stockholder’s Newsletter, Financial Report As Of September 30, 2012” that:
As of October 15, 2012, there were 12,400 DROSPIRENONE LAWSUITS pending in the United States that had been served upon the company. An additional 720 claims were disclosed as pending but yet filed of record in court. The number of claimants in pending lawsuits and claims totaled 13,500 excluding already settled cases.
As of October 15, 2012, BAYER had reached settlement agreements, in principle, with 3,490 claimants and agreed to pay about $750 Million U.S. Dollars. BAYER is only settled cases in the U.S. for venous clot injuries, including Pulmonary Embolism or Deep Vein Thrombosis, following a case specific analysis of medical records on a rolling basis. Another 3,800 such cases remain pending as unsettled cases.
Our office continues to provide FREE YAZ LAWSUIT CASE EVALUATIONS under no obligation to girls and women that suffered an injury following the use of aDROSPIRENONE (DRSP) containing birth control pill. Please contact us with any questions or requests in this regard. Gabriel F. Zambrano, of Farmer Jaffe Weissing, was one of the 1st lawyers to seek other lawyers to file lawsuits over DROSPIRENONE (DRSP) containing birth control pills. With him, our office continues to actively represent and Co-Counsel cases nationally that include some of the 1st women to file lawsuits against the manufacturer. Additional background information on the pills, their regulatory history and litigation is available at YAZ Recall and DRSP Recall. The DROSPIRENONE (DRSP) family of contraceptives narrowly escaped a market withdrawal during December 2011 and continue available on the market despite the number of lawsuits filed and estimates that settlements will exceed $2 Billion U.S. Dollars.